Cargando…

Covalent Inhibition of Pyruvate Kinase M2 Reprograms Metabolic and Inflammatory Pathways in Hepatic Macrophages against Non-alcoholic Fatty Liver Disease

Warburg effect of aerobic glycolysis in hepatic M1 macrophages is a major cause for metabolic dysfunction and inflammatory stress in non-alcoholic fatty liver disease (NAFLD). Plant-derived triterpene celastrol markedly inhibited macrophage M1 polarization and adipocyte hypertrophy in obesity. The p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Ni, Zhang, Xiuying, Zhao, Wei, Zhao, Jia, Luo, Dan, Sun, Yilu, Li, Ding, Zhao, Chenliang, Wang, Yu, Zhang, Hongjie, Rong, Jianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461663/ https://www.ncbi.nlm.nih.gov/pubmed/36147457 http://dx.doi.org/10.7150/ijbs.73890

Ejemplares similares

Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase
por: Battisti, Umberto Maria, et al.
Publicado: (2022)

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
por: Li, Jialin, et al.
Publicado: (2017)

Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming
por: Palmieri, Erika M., et al.
Publicado: (2023)

Covalent inhibition of endoplasmic reticulum chaperone GRP78 disconnects the transduction of ER stress signals to inflammation and lipid accumulation in diet-induced obese mice
por: Luo, Dan, et al.
Publicado: (2022)

Inhibition of pyruvate dehydrogenase kinase-1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming
por: Xu, Huadan, et al.
Publicado: (2020)

Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2014)

Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation
por: Yuan, Qi, et al.
Publicado: (2020)

Pyruvate dehydrogenase kinase supports macrophage NLRP3 inflammasome activation during acute inflammation
por: Meyers, Allison K., et al.
Publicado: (2023)

Pyruvate Kinase Is Required for Sex Pheromone Biosynthesis in Helicoverpa armigera
por: Yao, Shuangyan, et al.
Publicado: (2021)

Upregulation of Small Ubiquitin-Like Modifier 2 and Protein SUMOylation as a Cardioprotective Mechanism Against Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei, et al.
Publicado: (2021)

SUMOylation of Nuclear γ-Actin by SUMO2 supports DNA Damage Repair against Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei, et al.
Publicado: (2022)

Pyruvate dehydrogenase kinase regulates hepatitis C virus replication
por: Jung, Gwon-Soo, et al.
Publicado: (2016)

Parkin Regulates the Activity of Pyruvate Kinase M2
por: Liu, Kun, et al.
Publicado: (2016)

Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
por: Li, Xiaoli, et al.
Publicado: (2017)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

Pyruvate dehydrogenase kinase is a negative regulator of interleukin-10 production in macrophages
por: Na, Yi Rang, et al.
Publicado: (2020)

Dissecting the molecular mechanisms underlying the antidepressant activities of herbal medicines through the comprehensive review of the recent literatures
por: Sun, Yilu, et al.
Publicado: (2022)

Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
por: Zhan, Cheng, et al.
Publicado: (2015)

Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression
por: Zhao, Hongying, et al.
Publicado: (2023)

Changes in nitrogen availability lead to a reprogramming of pyruvate metabolism
por: Fataftah, Nazeer, et al.
Publicado: (2018)

SUMOylation as a Therapeutic Target for Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2021)

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype
por: Min, Byong-Keol, et al.
Publicado: (2019)

Pyruvate dehydrogenase kinase 4‐mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B‐cell lymphoma by affecting the expression of MS4A1/CD20
por: Jiang, Duanfeng, et al.
Publicado: (2021)

Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer
por: Deng, Xinyue, et al.
Publicado: (2020)

Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease‐specific assessments
por: Salek, Sam, et al.
Publicado: (2020)

Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
por: Zhao, Zheng, et al.
Publicado: (2022)

Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
por: Li, Aiyun, et al.
Publicado: (2018)

Kinetic Characterization and Inhibitor Screening of Pyruvate Kinase I From Babesia microti
por: An, Xiaomeng, et al.
Publicado: (2021)

Transcriptional Regulation of Pyruvate Dehydrogenase Kinase
por: Jeong, Ji Yun, et al.
Publicado: (2012)

An engineered photoswitchable mammalian pyruvate kinase
por: Gehrig, Stefanie, et al.
Publicado: (2017)

Molecular heterogeneity of pyruvate kinase deficiency
por: Bianchi, Paola, et al.
Publicado: (2020)

Pyruvate Kinase, Inflammation and Periodontal Disease
por: Grant, Melissa M.
Publicado: (2021)

Pyruvate Kinase Deficiency Causing Priapism
por: Shankar, Vinay Hanyalu, et al.
Publicado: (2023)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells
por: Almouhanna, Fadi, et al.
Publicado: (2021)

Genetic Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin Resistance Induced Diabetes
por: Tao, Rongya, et al.
Publicado: (2013)

Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease
por: Fukushima, Hisataka, et al.
Publicado: (2020)

HSP40 Interacts with Pyruvate Kinase M2 and Regulates Glycolysis and Cell Proliferation in Tumor Cells
por: Huang, Liangqian, et al.
Publicado: (2014)

Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4
por: Deng, Wenyi, et al.
Publicado: (2022)

The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
por: Zhang, Shuai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tg6sa19qb4m4i3jln4iphl9gv9